Published in Mol Ther on October 28, 2013
Recent advances in the genetic neuropathies. Curr Opin Neurol (2016) 1.40
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. Orphanet J Rare Dis (2014) 1.00
AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models. Ann Clin Transl Neurol (2015) 0.95
A brief review of recent Charcot-Marie-Tooth research and priorities. F1000Res (2015) 0.86
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management. Appl Clin Genet (2015) 0.78
Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats. Elife (2016) 0.77
Gene therapy, CMT1X, and the inherited neuropathies. Proc Natl Acad Sci U S A (2016) 0.77
Effects of exogenous neurotrophin-3 on myocyte apoptosis and Ca(2+)-ATP enzyme levels following nerve injury in rats. Int J Clin Exp Med (2015) 0.75
Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int J Mol Sci (2017) 0.75
Promoting peripheral myelin repair. Exp Neurol (2016) 0.75
Assaying the Stability and Inactivation of AAV Serotype 1 Vectors. Hum Gene Ther Methods (2017) 0.75
AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy. Gene Ther (2015) 0.75
Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach. J Multidiscip Healthc (2016) 0.75
DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell (1991) 7.93
Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet (1974) 5.80
Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord (1991) 3.37
Self-complementary AAV vectors; advances and applications. Mol Ther (2008) 3.10
Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature (1993) 3.09
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell (1991) 2.97
Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell (1992) 2.80
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther (1999) 2.73
Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci (1998) 2.17
Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res (1996) 2.12
The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron (1992) 2.11
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain (2000) 2.10
Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery (1998) 2.07
Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol (1999) 1.81
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology (2005) 1.63
Specificity of peripheral nerve regeneration: interactions at the axon level. Prog Neurobiol (2012) 1.55
Neurotrophin receptor genes are expressed in distinct patterns in developing dorsal root ganglia. J Neurosci (1993) 1.54
E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol Cell Biol (1996) 1.54
Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther (2008) 1.48
Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases. Proc Natl Acad Sci U S A (2004) 1.47
A novel PMP22 point mutation causing HNPP phenotype: studies on nerve xenografts. Neurology (1998) 1.44
Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci (1995) 1.41
Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia (2000) 1.37
Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Natl Acad Sci U S A (2001) 1.33
Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci (1999) 1.25
Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med (2006) 1.24
Expression of neurotrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function. J Neurosci Res (1995) 1.20
Schwann cells as regulators of nerve development. J Physiol Paris (2001) 1.13
Combined scatter diagrams of sheath thickness and fibre calibre in human sural nerves: changes with age and neuropathy. J Neurol Neurosurg Psychiatry (1985) 1.12
Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia (1997) 1.07
17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. J Neurol (2005) 1.05
Long-term changes in neurotrophic factor expression in distal nerve stump following denervation and reinnervation with motor or sensory nerve. J Neurochem (2008) 0.99
The nature of myelinated nerve fiber degeneration in dominantly inherited hypertrophic neuropathy. Mayo Clin Proc (1974) 0.98
Neurotrophin-3-enhanced nerve regeneration selectively improves recovery of muscle fibers expressing myosin heavy chains 2b. J Cell Biol (1997) 0.96
Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J Neurosci Res (1998) 0.95
Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy. J Neuropathol Exp Neurol (1979) 0.94
Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci (1990) 0.92
Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. Eur J Neurosci (1997) 0.92
Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination. Ann N Y Acad Sci (1999) 0.90
Factors influencing the course of regeneration and the quality of the recovery after nerve suture. Brain (1952) 0.89
A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci (1999) 0.87
Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A? J Peripher Nerv Syst (2004) 0.85
TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Exp Neurol (2010) 0.85
Electrophysiologic findings and grip strength after nerve injuries in the rat forelimb. Muscle Nerve (2008) 0.84
Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis. J Neuropathol Exp Neurol (1998) 0.81
Neurotrophins and peripheral neuropathies. Brain Pathol (2006) 0.79
Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts. J Peripher Nerv Syst (2003) 0.79
Neurotrophin-3 deficient Schwann cells impair nerve regeneration. Exp Neurol (2008) 0.78